Solid Tumours

Solid Tumours
2023-08-22T00:00:00.000+10:00
Ongoing

STARSTRUCK

STARSTRUCK
Solid Tumours

Open label, single-arm, multicentre dose escalation (Part 1) and dose expansion (Part 2) study to evaluate different combinations of 3 radioactive dose levels of 177Lu-TLX250 administered intravenously with 3 different doses of peposertib in patients with CAIX-expressing solid tumours.

A Phase 1b Dose Escalation/Expansion Study of the Combination of 177Lu-TLX250 and Peposertib in Patients with Carbonic Anhydrase IX (CAIX)-Expressing Solid Tumors.

Trial overview

Clinical Area

Theranostics

Disease / Condition

Solid tumours

Study Phase

Ib

Trial Identifiers

Registration number: NCT05868174

https://www.clinicaltrials.gov/study/NCT05868174

 

GenesisCare Location(s)
Murdoch (Oncology)
location pin icon

St John of God Murdoch Hospital, 100 Murdoch Drive, Murdoch, WA, 6150, Australia

phone icon (08) 9366 1500 email icon receptiononcologymurdoch@genesiscare.com
WA
Murdoch (Oncology)
North Shore
location pin icon

North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia

phone icon (02) 8037 4100 email icon admin.northshore@genesiscare.com
NSW
North Shore
Principal Investigator(s)
Nuclear Medicine Physician

Dr Aviral Singh

MD PGDipCard MSc FAfNM FRACP - Clinical Head of Theranostics and Nuclear Medicine

Dr Aviral Singh
location pin icon

Murdoch (Oncology)

View Profile
Profile Image - Dr Aviral Singh
Medical Oncologist

Dr Adrian Lee

BSc (Med) MBBS (Hons) FRACP PhD

Dr Adrian Lee
location pin icon

North Shore

View Profile
Profile Image - Dr Adrian Lee

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.